Next 10 |
home / stock / bsx / bsx articles
Intuitive Surgical (NASDAQ: ISRG) is witnessing strong momentum, with its shares having rallied 26.4% year to date compared with 6.1% growth of the...
Boston Scientific Corporation (NYSE: BSX) is scheduled to report second-quarter 2024 results on Jul 24, before the opening bell. In the last r...
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry obse...
West Pharmaceutical Services, Inc. (NYSE: WST) is well poised for growth, backed by the robust Proprietary Products segment and sustained strength ...
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.07% on an annualized basis producing an average annual return ...
McKesson Corporation's (NYSE: MCK) Biologics by McKesson, its independent specialty pharmacy specializing in oncology and rare disease areas, h...
The Zacks Medical – Products industry's revenues are expected to continue its growth trajectory on the back of the recovery in demand for...
BrainsWay Ltd. (NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute ho...
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports abo...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
2024-09-04 10:15:04 ET Raymond James analyst issues STRONG BUY recommendation for BSX on September 4, 2024 08:43AM ET. The previous analyst recommendation was Strong Buy. BSX was trading at $81.6 at issue of the analyst recommendation. The overall analyst consensus : BUY...
Boston Scientific Obtains CE Mark for ACURATE Prime™ Aortic Valve System PR Newswire MARLBOROUGH, Mass. , Aug. 27, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has obtained CE mark for the ACURATE Prime™ Aortic V...
2024-08-26 09:00:00 ET Medtronic (NYSE: MDT) posted first-quarter earnings (for the period ended on June 30) that exceeded the average of Wall Street estimates. The results were strong enough for the medical technologies giant to raise its full-year profit forecast. Investors sh...